Evidence map›Paper›PMID 41142001›Full record

ArticleFrontiers in pediatrics2025

Evaluation of gestational age, serum amyloid A, and hemoglobin decline (ΔHb) as diagnostic markers for NEC secondary to late-onset sepsis in preterm infants.

Yun Cheng, Biquan Chen, Wenjia Tong, Wangqiang Li, Yuanyuan Duan

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yun ChengDepartment of Infection, Anhui Provincial Children's Hospital, Hefei, China.
Biquan ChenDepartment of Infection, Anhui Provincial Children's Hospital, Hefei, China.
Wenjia TongDepartment of Infection, Anhui Provincial Children's Hospital, Hefei, China.
Wangqiang LiDepartment of Infection, Anhui Provincial Children's Hospital, Hefei, China.
Yuanyuan DuanDepartment of Infection, Anhui Provincial Children's Hospital, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate gestational age, serum amyloid A (SAA), and hemoglobin decline (ΔHb) as diagnostic markers for necrotizing enterocolitis (NEC) secondary to late-onset sepsis (LOS) in preterm infants. Methods: A retrospective study was conducted on 77 preterm infants with LOS admitted to Anhui Provincial Children's Hospital from January 1, 2019, to October 31, 2024. The infants were divided into an NEC group (24 cases) and a non-NEC group (53 cases). Perinatal factors, initial blood counts, C-reactive protein, and SAA levels during early LOS were recorded. ΔHb was calculated as the difference between pre-LOS Hb concentration and initial Hb concentration at LOS onset. Differences were analyzed using the Mann-Whitney Results: The NEC group had significantly lower birth weight, gestational age, white blood cell count, neutrophil count, and lymphocyte count compared to the non-NEC group. In contrast, SAA, ΔHb, asphyxia incidence, and ventilator use rate were significantly higher in the NEC group ( Conclusion: Gestational age, SAA, and ΔHb appear to be useful indicators for predicting NEC secondary to LOS in preterm infants. The ease of obtaining these indicators and their low cost make them suitable for clinical application. However, this study was retrospective with certain uncontrollable factors and a relatively small sample size. Larger prospective studies are recommended for further validation.

Indexed as

gestational agehemoglobinlate-onset sepsisnecrotizing enterocolitispreterm infantsserum amyloid A

Identifiers

PMID41142001
PMCPMC12545128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.